Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq of LPS-challenged microglial cell treatment with TOP1 inhibitor

ABSTRACT: RNA-seq of LPS-challenged microglial cell treatment with TOP1 inhibitor

PROVIDER: PRJEB46100 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR6184410_1.fastq.gz	Fastqsanger.gz
	ERR6184410_2.fastq.gz	Fastqsanger.gz
	ERR6184411_1.fastq.gz	Fastqsanger.gz
	ERR6184411_2.fastq.gz	Fastqsanger.gz
	ERR6184412_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 18

Similar Datasets

RNA-seq of LPS-challenged microglial cell treatment with TOP1 inhibitor

Project description:This dataset contains the RNA-seq data generated to investigate the mechanism of TOP1 inhibitor topotecan (TPT)'s role of anti-inflammation in microglial. RNA from mouse microgial cells, cells with LPS treatment to induce inflammation, and cells with LPS and TPT treatment were harvest and processed with polyA-tail enrichment RNA library preparation.

2022-04-27 | E-MTAB-10679 | biostudies-arrayexpress

Effect of C13 MOK-inhibitor on LPS-induced responses in primary microglial cells

Project description:To investigate the possible impact of MOK in microglial immune responses, we tested the effect of MOK-inhibition with the chemical compound C13, in LPS-stimulated microglial cells.

2023-06-30 | GSE233719 | GEO

Effect of C13 MOK-inhibitor on LPS-induced responses in primary microglial cells

Project description:Effect of C13 MOK-inhibitor on LPS-induced responses in primary microglial cells

| PRJNA977653 | ENA

Data sets of microglia isolated from C57BL/6 WT mice and animals harboring microglial IL10Ra and TNF mutations, at steady state or after peripheral LPS challenge (RNAseq) and WT microglia with and without peripheral LPS challenge (ATACseq)

Project description:To define the microglia response to septicemia, C57BL/6 WT mice and animals harboring microglial IL10Ra and TNF mutations were challenged with LPS and microglia were sorted for RNAseq analysis (WT, mutants) aor ATACseq (WT).

2020-09-02 | GSE157234 | GEO

LPS and Telmisartan co-treatment of microglial BV2 cells

Project description:LPS and Telmisartan co-treatment of microglial BV2 cells.

2018-07-02 | GSE108669 | GEO

RNA sequencing reveals resistance of TLR4 ligand-activated microglial cells to inflammation mediated by the selective jumonji H3K27 demethylase inhibitor

Project description:Persistent microglia activation is associated with the production and secretion of various pro-inflammatory genes, cytokines and chemokines, which may initiate or amplify neurodegenerative diseases. A novel synthetic histone 3 lysine 27 (H3K27) demethylases JMJD3 inhibitor, GSK-J4, was proven to exert immunosuppressive activities in macrophages. However, a genome-wide search for GSK-J4 molecular targets has not been undertaken in microglia. To study the immuno-modulatory effects of GSK-J4 on a transcriptomic level, triplicate RNA sequencing and quantitative real-time PCR analyses were performed with resting, GSK-J4, LPS and LPS+GSK-J4 challenged primary microglial (PM) and BV-2 microglial cells. Among the annotated genes, transcriptional sequencing of microglia that were treated with GSKJ4 revealed a selective effect on LPS induced gene expression in which the induction of cytokines/chemokines, interferon-stimulated genes, and prominent (transcription factors) TFs as well as previously unidentified genes that are important in inflammation was suppressed. Furthermore, we show that GSK-J4 controls important inflammatory genes targets by modulating STAT1, IRF7, and H3K27me3 level at their promoter site. These unprecedented results demonstrate the histone demethylases inhibitor GSK-J4 could have therapeutic applications for neuroinflammatory diseases.

2017-08-31 | GSE89817 | GEO

LPS, Telmisartan and GW9662 co-treatment of microglial BV2 cells

Project description:LPS, Telmisartan and GW9662 co-treatment of microglial BV2 cells.

2018-07-02 | GSE108670 | GEO

Transcription profiles of BV2 microglial cell lines- unstimulated or stimulated with LPS or transfected with constitutively active Stat1 and Stat3.

Project description:Transcription profiles of BV2 microglial cell lines: unstimulated, stimulated with LPS or transfected with constitutively active Stat1 and Stat3.

2014-06-19 | E-MEXP-3659 | biostudies-arrayexpress

Effect of MOK in LPS-induced responses in microglial cells

Project description:To investigate the possible impact of MOK in microglial immune responses, we tested the effect of LPS treatment in MOK-KO (H14) vs. WT SIM-A9 cells.

2023-06-30 | GSE234160 | GEO

LPS, Telmisartan and GW9662 treatment of microglial BV2 cells

Project description:LPS, Telmisartan and GW9662 treatment of microglial BV2 cells

| PRJNA428232 | ENA